Milestone Pharmaceuticals, Inc. (MIST)
0.7528
+0.04
(+5.72%)
USD |
NASDAQ |
Oct 09, 12:12
Milestone Pharmaceuticals 30-Day Average Daily Volume : 1.347M for Oct. 8, 2026
30-Day Average Daily Volume Chart
Historical 30-Day Average Daily Volume Data
| Date | Value |
|---|---|
| October 08, 2026 | 1.347M |
| October 07, 2026 | 1.325M |
| October 06, 2026 | 1.352M |
| October 05, 2026 | 1.358M |
| October 02, 2026 | 1.386M |
| October 01, 2026 | 1.433M |
| September 30, 2026 | 1.486M |
| September 29, 2026 | 1.493M |
| September 28, 2026 | 1.515M |
| September 25, 2026 | 1.573M |
| September 24, 2026 | 1.620M |
| September 23, 2026 | 1.735M |
| September 22, 2026 | 1.731M |
| September 21, 2026 | 1.727M |
| September 18, 2026 | 1.738M |
| September 17, 2026 | 1.739M |
| September 16, 2026 | 1.726M |
| September 15, 2026 | 1.718M |
| September 14, 2026 | 1.684M |
| September 11, 2026 | 1.634M |
| September 10, 2026 | 1.581M |
| September 09, 2026 | 1.618M |
| September 08, 2026 | 1.661M |
| September 04, 2026 | 1.642M |
| September 03, 2026 | 1.618M |
| Date | Value |
|---|---|
| September 02, 2026 | 1.584M |
| September 01, 2026 | 1.581M |
| August 31, 2026 | 1.562M |
| August 28, 2026 | 1.552M |
| August 27, 2026 | 1.576M |
| August 26, 2026 | 1.549M |
| August 25, 2026 | 1.550M |
| August 24, 2026 | 1.522M |
| August 21, 2026 | 1.487M |
| August 20, 2026 | 1.439M |
| August 19, 2026 | 1.393M |
| August 18, 2026 | 1.422M |
| August 17, 2026 | 1.420M |
| August 14, 2026 | 1.391M |
| August 13, 2026 | 1.353M |
| August 12, 2026 | 1.300M |
| August 11, 2026 | 1.182M |
| August 10, 2026 | 1.208M |
| August 07, 2026 | 1.184M |
| August 06, 2026 | 1.246M |
| August 05, 2026 | 1.251M |
| August 04, 2026 | 1.279M |
| August 03, 2026 | 1.293M |
| July 31, 2026 | 1.307M |
| July 30, 2026 | 1.350M |
30-Day Average Daily Volume Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
30-Day Average Daily Volume Benchmarks
| InMed Pharmaceuticals, Inc. | 60419.70 |
| NervGen Pharma Corp. | 547645.5 |
| Clearmind Medicine, Inc. | 110652.7 |
| Lexaria Bioscience Corp. | 105374.1 |
| Target Group, Inc. (Canada) | 314051.2 |